Cargando…
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
KEY POINTS: Kidney survival in C3 glomerulopathy is significantly higher in patients with a disease chronicity score <4 and proteinuria <3.5 g/d, regardless of baseline eGFR. A faster eGFR decline in C3 glomerulopathy is associated with higher probability of kidney failure. Patients with glome...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Nephrology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278771/ https://www.ncbi.nlm.nih.gov/pubmed/36996481 http://dx.doi.org/10.34067/KID.0000000000000115 |
_version_ | 1785060547993010176 |
---|---|
author | Caravaca-Fontán, Fernando Cavero, Teresa Díaz-Encarnación, Montserrat Cabello, Virginia Ariceta, Gema Quintana, Luis F. Marco, Helena Barros, Xoana Ramos, Natalia Rodríguez-Mendiola, Nuria Cruz, Sonia Fernández-Juárez, Gema Rodríguez, Adela Pérez de José, Ana Rabasco, Cristina Rodado, Raquel Fernández, Loreto Pérez-Gómez, Vanessa Ávila, Ana Bravo, Luis Espinosa, Natalia Allende, Natalia Sanchez de la Nieta, Maria Dolores Rodríguez, Eva Rivas, Begoña Melgosa, Marta Huerta, Ana Miquel, Rosa Mon, Carmen Fraga, Gloria de Lorenzo, Alberto Draibe, Juliana González, Fayna Shabaka, Amir López-Rubio, Maria Esperanza Fenollosa, María Ángeles Martín-Penagos, Luis Da Silva, Iara Titos, Juana Alonso Rodríguez de Córdoba, Santiago Goicoechea de Jorge, Elena Praga, Manuel |
author_facet | Caravaca-Fontán, Fernando Cavero, Teresa Díaz-Encarnación, Montserrat Cabello, Virginia Ariceta, Gema Quintana, Luis F. Marco, Helena Barros, Xoana Ramos, Natalia Rodríguez-Mendiola, Nuria Cruz, Sonia Fernández-Juárez, Gema Rodríguez, Adela Pérez de José, Ana Rabasco, Cristina Rodado, Raquel Fernández, Loreto Pérez-Gómez, Vanessa Ávila, Ana Bravo, Luis Espinosa, Natalia Allende, Natalia Sanchez de la Nieta, Maria Dolores Rodríguez, Eva Rivas, Begoña Melgosa, Marta Huerta, Ana Miquel, Rosa Mon, Carmen Fraga, Gloria de Lorenzo, Alberto Draibe, Juliana González, Fayna Shabaka, Amir López-Rubio, Maria Esperanza Fenollosa, María Ángeles Martín-Penagos, Luis Da Silva, Iara Titos, Juana Alonso Rodríguez de Córdoba, Santiago Goicoechea de Jorge, Elena Praga, Manuel |
author_sort | Caravaca-Fontán, Fernando |
collection | PubMed |
description | KEY POINTS: Kidney survival in C3 glomerulopathy is significantly higher in patients with a disease chronicity score <4 and proteinuria <3.5 g/d, regardless of baseline eGFR. A faster eGFR decline in C3 glomerulopathy is associated with higher probability of kidney failure. Patients with glomerulopathy with a progressive reduction in proteinuria over time did not reach kidney failure. BACKGROUND: C3 glomerulopathy is a rare kidney disease, which makes it difficult to collect large cohorts of patients to better understand its variability. The aims of this study were to describe the clinical profiles and patterns of progression of kidney disease. METHODS: This was a retrospective, observational cohort study. Patients diagnosed with C3 glomerulopathy between 1995 and 2020 were enrolled. Study population was divided into clinical profiles by combining the following predictors: eGFR under/above 30 ml/min per 1.73 m(2), proteinuria under/above 3.5 g/d, and histologic chronicity score under/above 4. The change in eGFR and proteinuria over time was evaluated in a subgroup with consecutive measurements of eGFR and proteinuria. RESULTS: One hundred and fifteen patients with a median age of 30 years (interquartile range 19–50) were included. Patients were divided into eight clinical profiles. Kidney survival was significantly higher in patients with a chronicity score <4 and proteinuria <3.5 g/d, both in those presenting with an eGFR under/above 30 ml/min per 1.73 m(2). The median eGFR slope of patients who reached kidney failure was −6.5 ml/min per 1.73 m(2) per year (interquartile range −1.6 to −17). Patients who showed a reduction in proteinuria over time did not reach kidney failure. On the basis of the rate of eGFR decline, patients were classified as faster eGFR decline (≥5 ml/min per 1.73 m(2) per year), slower (<5 ml/min per 1.73 m(2) per year), and those without decline. A faster eGFR decline was associated with higher probability of kidney failure. CONCLUSIONS: Kidney survival is significantly higher in patients with a chronicity score <4 and proteinuria <3.5 g/d regardless of baseline eGFR, and a faster rate of decline in eGFR is associated with higher probability of kidney failure. |
format | Online Article Text |
id | pubmed-10278771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Society of Nephrology |
record_format | MEDLINE/PubMed |
spelling | pubmed-102787712023-08-03 Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy Caravaca-Fontán, Fernando Cavero, Teresa Díaz-Encarnación, Montserrat Cabello, Virginia Ariceta, Gema Quintana, Luis F. Marco, Helena Barros, Xoana Ramos, Natalia Rodríguez-Mendiola, Nuria Cruz, Sonia Fernández-Juárez, Gema Rodríguez, Adela Pérez de José, Ana Rabasco, Cristina Rodado, Raquel Fernández, Loreto Pérez-Gómez, Vanessa Ávila, Ana Bravo, Luis Espinosa, Natalia Allende, Natalia Sanchez de la Nieta, Maria Dolores Rodríguez, Eva Rivas, Begoña Melgosa, Marta Huerta, Ana Miquel, Rosa Mon, Carmen Fraga, Gloria de Lorenzo, Alberto Draibe, Juliana González, Fayna Shabaka, Amir López-Rubio, Maria Esperanza Fenollosa, María Ángeles Martín-Penagos, Luis Da Silva, Iara Titos, Juana Alonso Rodríguez de Córdoba, Santiago Goicoechea de Jorge, Elena Praga, Manuel Kidney360 Original Investigation KEY POINTS: Kidney survival in C3 glomerulopathy is significantly higher in patients with a disease chronicity score <4 and proteinuria <3.5 g/d, regardless of baseline eGFR. A faster eGFR decline in C3 glomerulopathy is associated with higher probability of kidney failure. Patients with glomerulopathy with a progressive reduction in proteinuria over time did not reach kidney failure. BACKGROUND: C3 glomerulopathy is a rare kidney disease, which makes it difficult to collect large cohorts of patients to better understand its variability. The aims of this study were to describe the clinical profiles and patterns of progression of kidney disease. METHODS: This was a retrospective, observational cohort study. Patients diagnosed with C3 glomerulopathy between 1995 and 2020 were enrolled. Study population was divided into clinical profiles by combining the following predictors: eGFR under/above 30 ml/min per 1.73 m(2), proteinuria under/above 3.5 g/d, and histologic chronicity score under/above 4. The change in eGFR and proteinuria over time was evaluated in a subgroup with consecutive measurements of eGFR and proteinuria. RESULTS: One hundred and fifteen patients with a median age of 30 years (interquartile range 19–50) were included. Patients were divided into eight clinical profiles. Kidney survival was significantly higher in patients with a chronicity score <4 and proteinuria <3.5 g/d, both in those presenting with an eGFR under/above 30 ml/min per 1.73 m(2). The median eGFR slope of patients who reached kidney failure was −6.5 ml/min per 1.73 m(2) per year (interquartile range −1.6 to −17). Patients who showed a reduction in proteinuria over time did not reach kidney failure. On the basis of the rate of eGFR decline, patients were classified as faster eGFR decline (≥5 ml/min per 1.73 m(2) per year), slower (<5 ml/min per 1.73 m(2) per year), and those without decline. A faster eGFR decline was associated with higher probability of kidney failure. CONCLUSIONS: Kidney survival is significantly higher in patients with a chronicity score <4 and proteinuria <3.5 g/d regardless of baseline eGFR, and a faster rate of decline in eGFR is associated with higher probability of kidney failure. American Society of Nephrology 2023-03-30 /pmc/articles/PMC10278771/ /pubmed/36996481 http://dx.doi.org/10.34067/KID.0000000000000115 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Investigation Caravaca-Fontán, Fernando Cavero, Teresa Díaz-Encarnación, Montserrat Cabello, Virginia Ariceta, Gema Quintana, Luis F. Marco, Helena Barros, Xoana Ramos, Natalia Rodríguez-Mendiola, Nuria Cruz, Sonia Fernández-Juárez, Gema Rodríguez, Adela Pérez de José, Ana Rabasco, Cristina Rodado, Raquel Fernández, Loreto Pérez-Gómez, Vanessa Ávila, Ana Bravo, Luis Espinosa, Natalia Allende, Natalia Sanchez de la Nieta, Maria Dolores Rodríguez, Eva Rivas, Begoña Melgosa, Marta Huerta, Ana Miquel, Rosa Mon, Carmen Fraga, Gloria de Lorenzo, Alberto Draibe, Juliana González, Fayna Shabaka, Amir López-Rubio, Maria Esperanza Fenollosa, María Ángeles Martín-Penagos, Luis Da Silva, Iara Titos, Juana Alonso Rodríguez de Córdoba, Santiago Goicoechea de Jorge, Elena Praga, Manuel Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy |
title | Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy |
title_full | Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy |
title_fullStr | Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy |
title_full_unstemmed | Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy |
title_short | Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy |
title_sort | clinical profiles and patterns of kidney disease progression in c3 glomerulopathy |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278771/ https://www.ncbi.nlm.nih.gov/pubmed/36996481 http://dx.doi.org/10.34067/KID.0000000000000115 |
work_keys_str_mv | AT caravacafontanfernando clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT caveroteresa clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT diazencarnacionmontserrat clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT cabellovirginia clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT aricetagema clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT quintanaluisf clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT marcohelena clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT barrosxoana clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT ramosnatalia clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT rodriguezmendiolanuria clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT cruzsonia clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT fernandezjuarezgema clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT rodriguezadela clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT perezdejoseana clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT rabascocristina clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT rodadoraquel clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT fernandezloreto clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT perezgomezvanessa clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT avilaana clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT bravoluis clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT espinosanatalia clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT allendenatalia clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT sanchezdelanietamariadolores clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT rodriguezeva clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT rivasbegona clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT melgosamarta clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT huertaana clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT miquelrosa clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT moncarmen clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT fragagloria clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT delorenzoalberto clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT draibejuliana clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT gonzalezfayna clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT shabakaamir clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT lopezrubiomariaesperanza clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT fenollosamariaangeles clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT martinpenagosluis clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT dasilvaiara clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT titosjuanaalonso clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT rodriguezdecordobasantiago clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT goicoecheadejorgeelena clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy AT pragamanuel clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy |